Cargando…

Antibody signatures of asymptomatic Plasmodium falciparum malaria infections measured from dried blood spots

BACKGROUND: Screening malaria-specific antibody responses on protein microarrays can help identify immune factors that mediate protection against malaria infection, disease, and transmission, as well as markers of past exposure to both malaria parasites and mosquito vectors. Most malaria protein mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Markwalter, Christine F., Nyunt, Myat Htut, Han, Zay Yar, Henao, Ricardo, Jain, Aarti, Taghavian, Omid, Felgner, Philip L., Han, Kay Thwe, Nyunt, Myaing M., Plowe, Christopher V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461960/
https://www.ncbi.nlm.nih.gov/pubmed/34556121
http://dx.doi.org/10.1186/s12936-021-03915-8
_version_ 1784572098174255104
author Markwalter, Christine F.
Nyunt, Myat Htut
Han, Zay Yar
Henao, Ricardo
Jain, Aarti
Taghavian, Omid
Felgner, Philip L.
Han, Kay Thwe
Nyunt, Myaing M.
Plowe, Christopher V.
author_facet Markwalter, Christine F.
Nyunt, Myat Htut
Han, Zay Yar
Henao, Ricardo
Jain, Aarti
Taghavian, Omid
Felgner, Philip L.
Han, Kay Thwe
Nyunt, Myaing M.
Plowe, Christopher V.
author_sort Markwalter, Christine F.
collection PubMed
description BACKGROUND: Screening malaria-specific antibody responses on protein microarrays can help identify immune factors that mediate protection against malaria infection, disease, and transmission, as well as markers of past exposure to both malaria parasites and mosquito vectors. Most malaria protein microarray work has used serum as the sample matrix, requiring prompt laboratory processing and a continuous cold chain, thus limiting applications in remote locations. Dried blood spots (DBS) pose minimal biohazard, do not require immediate laboratory processing, and are stable at room temperature for transport, making them potentially superior alternatives to serum. The goals of this study were to assess the viability of DBS as a source for antibody profiling and to use DBS to identify serological signatures of low-density Plasmodium falciparum infections in malaria-endemic regions of Myanmar. METHODS: Matched DBS and serum samples from a cross-sectional study in Ingapu Township, Myanmar were probed on protein microarrays populated with P. falciparum antigen fragments. Signal and trends in both sample matrices were compared. A case-control study was then performed using banked DBS samples from malaria-endemic regions of Myanmar, and a regularized logistic regression model was used to identify antibody signatures of ultrasensitive PCR-positive P. falciparum infections. RESULTS: Approximately 30% of serum IgG activity was recovered from DBS. Despite this loss of antibody activity, antigen and population trends were well-matched between the two sample matrices. Responses to 18 protein fragments were associated with the odds of asymptomatic P. falciparum infection, albeit with modest diagnostic characteristics (sensitivity 58%, specificity 85%, negative predictive value 88%, and positive predictive value 52%). CONCLUSIONS: Malaria-specific antibody responses can be reliably detected, quantified, and analysed from DBS, opening the door to serological studies in populations where serum collection, transport, and storage would otherwise be impossible. While test characteristics of antibody signatures were insufficient for individual diagnosis, serological testing may be useful for identifying exposure to asymptomatic, low-density malaria infections, particularly if sero-surveillance strategies target individuals with low previous exposure as sentinels for population exposure. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-021-03915-8.
format Online
Article
Text
id pubmed-8461960
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84619602021-09-24 Antibody signatures of asymptomatic Plasmodium falciparum malaria infections measured from dried blood spots Markwalter, Christine F. Nyunt, Myat Htut Han, Zay Yar Henao, Ricardo Jain, Aarti Taghavian, Omid Felgner, Philip L. Han, Kay Thwe Nyunt, Myaing M. Plowe, Christopher V. Malar J Research BACKGROUND: Screening malaria-specific antibody responses on protein microarrays can help identify immune factors that mediate protection against malaria infection, disease, and transmission, as well as markers of past exposure to both malaria parasites and mosquito vectors. Most malaria protein microarray work has used serum as the sample matrix, requiring prompt laboratory processing and a continuous cold chain, thus limiting applications in remote locations. Dried blood spots (DBS) pose minimal biohazard, do not require immediate laboratory processing, and are stable at room temperature for transport, making them potentially superior alternatives to serum. The goals of this study were to assess the viability of DBS as a source for antibody profiling and to use DBS to identify serological signatures of low-density Plasmodium falciparum infections in malaria-endemic regions of Myanmar. METHODS: Matched DBS and serum samples from a cross-sectional study in Ingapu Township, Myanmar were probed on protein microarrays populated with P. falciparum antigen fragments. Signal and trends in both sample matrices were compared. A case-control study was then performed using banked DBS samples from malaria-endemic regions of Myanmar, and a regularized logistic regression model was used to identify antibody signatures of ultrasensitive PCR-positive P. falciparum infections. RESULTS: Approximately 30% of serum IgG activity was recovered from DBS. Despite this loss of antibody activity, antigen and population trends were well-matched between the two sample matrices. Responses to 18 protein fragments were associated with the odds of asymptomatic P. falciparum infection, albeit with modest diagnostic characteristics (sensitivity 58%, specificity 85%, negative predictive value 88%, and positive predictive value 52%). CONCLUSIONS: Malaria-specific antibody responses can be reliably detected, quantified, and analysed from DBS, opening the door to serological studies in populations where serum collection, transport, and storage would otherwise be impossible. While test characteristics of antibody signatures were insufficient for individual diagnosis, serological testing may be useful for identifying exposure to asymptomatic, low-density malaria infections, particularly if sero-surveillance strategies target individuals with low previous exposure as sentinels for population exposure. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-021-03915-8. BioMed Central 2021-09-23 /pmc/articles/PMC8461960/ /pubmed/34556121 http://dx.doi.org/10.1186/s12936-021-03915-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Markwalter, Christine F.
Nyunt, Myat Htut
Han, Zay Yar
Henao, Ricardo
Jain, Aarti
Taghavian, Omid
Felgner, Philip L.
Han, Kay Thwe
Nyunt, Myaing M.
Plowe, Christopher V.
Antibody signatures of asymptomatic Plasmodium falciparum malaria infections measured from dried blood spots
title Antibody signatures of asymptomatic Plasmodium falciparum malaria infections measured from dried blood spots
title_full Antibody signatures of asymptomatic Plasmodium falciparum malaria infections measured from dried blood spots
title_fullStr Antibody signatures of asymptomatic Plasmodium falciparum malaria infections measured from dried blood spots
title_full_unstemmed Antibody signatures of asymptomatic Plasmodium falciparum malaria infections measured from dried blood spots
title_short Antibody signatures of asymptomatic Plasmodium falciparum malaria infections measured from dried blood spots
title_sort antibody signatures of asymptomatic plasmodium falciparum malaria infections measured from dried blood spots
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461960/
https://www.ncbi.nlm.nih.gov/pubmed/34556121
http://dx.doi.org/10.1186/s12936-021-03915-8
work_keys_str_mv AT markwalterchristinef antibodysignaturesofasymptomaticplasmodiumfalciparummalariainfectionsmeasuredfromdriedbloodspots
AT nyuntmyathtut antibodysignaturesofasymptomaticplasmodiumfalciparummalariainfectionsmeasuredfromdriedbloodspots
AT hanzayyar antibodysignaturesofasymptomaticplasmodiumfalciparummalariainfectionsmeasuredfromdriedbloodspots
AT henaoricardo antibodysignaturesofasymptomaticplasmodiumfalciparummalariainfectionsmeasuredfromdriedbloodspots
AT jainaarti antibodysignaturesofasymptomaticplasmodiumfalciparummalariainfectionsmeasuredfromdriedbloodspots
AT taghavianomid antibodysignaturesofasymptomaticplasmodiumfalciparummalariainfectionsmeasuredfromdriedbloodspots
AT felgnerphilipl antibodysignaturesofasymptomaticplasmodiumfalciparummalariainfectionsmeasuredfromdriedbloodspots
AT hankaythwe antibodysignaturesofasymptomaticplasmodiumfalciparummalariainfectionsmeasuredfromdriedbloodspots
AT nyuntmyaingm antibodysignaturesofasymptomaticplasmodiumfalciparummalariainfectionsmeasuredfromdriedbloodspots
AT plowechristopherv antibodysignaturesofasymptomaticplasmodiumfalciparummalariainfectionsmeasuredfromdriedbloodspots